OCUL
Ocular Therapeutix, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.64
+0.00%Leverage
- Debt / equity
- 0.15x
- Net debt / equity
- -1.00x
- Debt / assets
- 0.12x
- Debt / EBITDA
- -0.28x
- Net debt / EBITDA
- 1.82x
Liquidity & coverage
- Current ratio
- 13.11x
- Quick ratio
- 13.03x
- Cash ratio
- 12.17x
- Interest coverage
- -27.53x
- EBITDA / interest
- -24.96x
- Working capital
- $595.3M
Cash & dividend
- FCF / debt
- -3.21x
- Cash flow / debt
- -3.00x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026